This is a $80,002 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the University of California, San Francisco (UCSF) for the preparation of tissue samples and medical records from never-smoking, Asian-American women with histologically confirmed lung cancer for the SHERLOCK-LUNG study. The study aims to identify exposure-related mutational signatures in lung cancer tumors from never-smoking women worldwide. The...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian federal agency, to the National Cancer Center, a Japanese research and development agency. The contract is for $24,000.00 and requires the awardee to provide laboratory testing services, including whole-genome scans and phenotype data preparation, on 1,000 never-smoking female lung adenocarcinoma cases in Japan. The contract has an ultimate completion date of December 9, 2025. This contract...
This is a firm-fixed price purchase order contract awarded by the National Institutes of Health (NIH), which is part of the U.S. Department of Health and Human Services (DHHS), to the National University of Singapore. The contract is for $105,750.00 to provide tissue sample and medical record preparation services in support of the SHERLOCK-LUNG study on never-smoking lung cancer cases in Singapore. This research supports the NIH's work in studying lung cancer. The National University of...
This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Regents of the University of California, San Francisco (UCSF) for the Cancer Genome Atlas (TCGA) program. The contract, valued at $24,087.50, is for the acquisition of tissue samples and data from various types of cancer to support the TCGA program, which is part of the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation and is a firm fixed-price type. UCSF, as...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $120,000.00 firm fixed price purchase order contract to The Chinese University of Hong Kong, an Other Not For Profit Organization, to recruit breast cancer patients and collect clinical and epidemiologic data and biospecimens. This contract does not have a set-aside designation. The Chinese University of Hong Kong has received three prior prime federal contract awards from the...
The Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $102,000.39 firm fixed-price purchase order contract to the University of Oxford to provide scientific input on the conduct and analysis of the NCI Sherlock Lung Project. The project aims to identify mutational signatures and develop an integrated molecular, histological, and radiological classification of lung cancer in never-smokers. The contract requires the...
The National Cancer Institute (NCI) awarded a $215,944 firm-fixed-price delivery order contract to the University of Southern California (USC) to conduct a Patterns of Care (POC)/Quality of Care Study for non-small cell lung cancer (NSCLC) diagnosed in 2017 and NSCLC and melanoma diagnosed in 2018. This contract is part of the larger Surveillance Epidemiology and End Results (SEER) program IDIQ contract, which allows NCI to issue task orders to USC for various cancer-related research and data...
The National Cancer Institute (NCI) awarded a $24,140 firm-fixed price purchase order to Trustees of Boston University, doing business as Boston University Medical Campus, for RNA sequencing and data processing of nasal epithelium samples from never-smoking women in Guatemala. This sole-source contract supports an intramural NCI study on the effects of smoky wood exposure. Boston University has specialized expertise in noninvasive sample collection and mRNA expression analysis of nasal tissue as...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $124,656 firm-fixed-price purchase order to the University of Hawaii Systems for the acquisition of cancer biospecimens and associated data. This sole-source award, which has no set-aside designation, will support the NCI's Center for Cancer Genomics' research on three major cancer types: Peripheral T Cell Lymphoma, Carcinomas of Unknown...
The University of California, San Francisco (UCSF) has been awarded a $155,104.99 delivery order contract by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The contract is part of the Surveillance, Epidemiology, and End Results (SEER) Program, which aims to collect and analyze data on cancer incidence and survival in the United States. Under this contract, UCSF will conduct a pilot project to develop and implement whole slide imaging capabilities for...
The U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) has awarded a $50,000.00 firm fixed-price purchase order to the Regents of the University of California, San Francisco (UCSF) to obtain historical samples of frozen tumor tissue and adjacent normal lung tissue from never-smoking lung cancer patients, along with accompanying medical documentation and data. This purchase order is part of the NCI's Sherlock-Lung study, an international whole-genome sequencing study of lung cancer tumors from never-smoking women worldwide, and is directly related to UCSF's ongoing Female Asian Never Smokers (FANS) study, a population-based case-control study on lung cancer in never-smoking Asian-American women. The contract does not have a set-aside designation.